NBY NOVABAY PHARMACEUTICALS INC Disposals and divestitures 8-K Filing 2025 - Asset Sale NovaBay Pharmaceuticals sold its Avenova eyecare brand and related assets to PRN for $11.5 million, with plans for liquidation pending stockholder approval. The company is also providing transition services to PRN and has adjourned a meeting to further solicit votes for its liquidation plan.Get access to all SEC 8-K filings of the NOVABAY PHARMACEUTICALS INC